tradingkey.logo
tradingkey.logo
Search

Magnera Fiscal Q3 2026 Earnings: EBITDA Rose as the Net Loss Widened

TradingKeyAug 5, 2026 11:07 PM
facebooktwitterlinkedin
View all comments0

Magnera (NYSE: MAGN) reported fiscal third-quarter 2026 net sales of $857 million, up 2% from $839 million, while diluted GAAP EPS was a loss of $0.56 versus a loss of $0.51 a year earlier. Adjusted EBITDA increased 9% to $99 million, but a $37 million interest expense and a shift from a tax benefit to a tax expense left the company with a wider $20 million net loss. The quarter ended June 27, 2026, and the results were released on August 5.

Core Financial Results

Reported sales benefited from a $21 million favorable currency impact and 1% organic volume growth, partly offset by an $8 million decrease in selling prices primarily related to unfavorable product mix net of raw-material pass-through. Volume benefited from global consumer solutions demand and a North American recovery from winter-storm disruptions in the preceding quarter. On a comparable basis that normalizes currency and merger effects, quarterly sales were essentially flat.

Cost of goods sold declined even as revenue increased, lifting derived gross profit and gross margin. The $11 million favorable price-cost spread was the primary driver of adjusted EBITDA growth, although higher SG&A and restructuring costs limited the improvement in GAAP earnings.

MetricFiscal Q3 2026Fiscal Q3 2025Year-over-year change
Net sales$857 million$839 million+2%
Gross profit, derivedApproximately $112 millionApproximately $90 millionApproximately +24%
Gross margin, derivedApproximately 13.1%Approximately 10.7%+2.3 percentage points
Operating income$22 million$13 million+$9 million
Net income (loss)$(20) million$(18) millionLoss widened by $2 million
Diluted EPS$(0.56)$(0.51)Loss widened by $0.05
Adjusted EBITDA$99 million$91 million+9%

Adjusted EBITDA is a non-GAAP measure. Its margin increased to approximately 11.6% from 10.8%, while the GAAP operating margin rose to approximately 2.6% from 1.5%.

Business and Segment Performance

The regional results diverged. Americas produced nearly all of the adjusted EBITDA growth, while Rest of World generated higher reported sales but lower EBITDA and moved to a GAAP operating loss.

SegmentNet salesSales changeAdjusted EBITDAEBITDA change
Americas$476 million+1%$71 million+16%
Rest of World$381 million+4%$28 million-7%

Americas sales included a $10 million currency benefit and 1% organic volume growth, partly offset by a $13 million decrease in selling prices associated mainly with negative product mix net of raw-material pass-through. Its EBITDA improvement reflected an $11 million favorable price-cost spread supported by Project CORE and merger synergies, partially offset by higher SG&A. GAAP operating income increased to $28 million from $12 million.

Rest of World sales benefited from an $11 million favorable currency movement and $5 million of higher selling prices tied to raw-material pass-through. However, Project CORE and synergy savings were offset by regional inflation, the timing of material cost pass-through and higher SG&A. Adjusted EBITDA declined by $2 million, while the segment recorded a $6 million operating loss compared with $1 million of operating income a year earlier.

Profitability, Cash Flow and Balance Sheet

Quarterly operating income improved to $22 million, but it remained below the $37 million interest expense. After another $3 million of other expense, Magnera reported a pretax loss of $18 million, narrower than the prior-year $24 million loss. The move from a $6 million tax benefit to a $2 million tax expense caused the net loss to widen despite the pretax improvement.

Cash-flow figures are reported for the first nine months of fiscal 2026 rather than for the quarter alone. Operating cash flow rose substantially, while lower capital additions helped produce positive free cash flow.

MetricJune 27, 2026ComparisonChange
Operating cash flow, nine months$76 million$7 million a year earlier+$69 million
Net property and equipment additions, nine months$44 million$52 million a year earlier-$8 million
Cash and cash equivalents$280 million$305 million at Sept. 27, 2025-$25 million
Total debt$1.901 billion$1.952 billion at Sept. 27, 2025-$51 million
Inventories$498 million$474 million at Sept. 27, 2025+$24 million

Nine-month free cash flow was $32 million after capital additions. Magnera also reported a trailing-12-month adjusted free cash flow yield above 25% at quarter-end and repaid $65 million of long-term borrowings during the first nine months.

Management Commentary

CEO Curt Begle attributed what management called a record third quarter to organic volume growth, Project CORE savings, merger synergies and pricing actions intended to manage higher costs for certain raw materials. The company said it was reaffirming its full-year free cash flow outlook while holding to the lower end of its adjusted EBITDA guidance range.

That positioning indicates that cash generation remains a priority, but management is not signaling performance above the lower end of its existing EBITDA range amid an uncertain macroeconomic and cost environment.

Recent Insider Transactions

The supplied insider data showed no recorded purchase or sale transactions during the latest six-month summary period, with total insider holdings of approximately 412,420 shares. The latest 10 reported transactions were all direct conversions from exercising derivative securities rather than open-market purchases or sales, so they do not by themselves indicate a directional view on the shares.

DateInsider and roleTransactionReported value
Feb. 27, 2026Jill L. Urey, General CounselDerivative exercise conversion at $12.95 per share$20,344
Feb. 24, 2026Jill L. Urey, General CounselDerivative exercise conversion at $13.03 per share$2,671
Nov. 4, 2025Carl John Rickertsen, DirectorDerivative exercise conversion at $8.53 per share$81,044
Nov. 4, 2025Bruce Brown, DirectorDerivative exercise conversion at $8.53 per share$81,044
Nov. 4, 2025Kevin Michael Fogarty, DirectorDerivative exercise conversion at $8.53 per share$81,044
Nov. 4, 2025Samantha J. Marnick, DirectorDerivative exercise conversion at $8.53 per share$81,044
Nov. 4, 2025Curtis L. Begle, CEODerivative exercise conversion at $8.53 per share$155,314
Nov. 4, 2025Michael S. Curless, DirectorDerivative exercise conversion at $8.53 per share$81,044
Nov. 4, 2025Jill L. Urey, General CounselDerivative exercise conversion at $8.53 per share$13,503
Nov. 4, 2025Thomas Fahnemann, DirectorDerivative exercise conversion at $8.53 per share$60,776

Risks Investors Need to Watch

  • Raw-material inflation and pass-through timing: Rest of World EBITDA declined because regional inflation and delayed material pass-through offset cost savings. Continued timing gaps could pressure margins.
  • Product mix and pricing: Consolidated selling prices declined by $8 million, including a $13 million decrease in Americas, primarily because of unfavorable mix net of raw-material pass-through.
  • Interest burden: Quarterly interest expense of $37 million exceeded operating income of $22 million, keeping pretax and net income negative despite improved operations.
  • Higher operating expenses: SG&A increased to $56 million from $50 million, while restructuring and other activity costs rose to $23 million from $14 million.
  • Dependence on cost initiatives: The EBITDA improvement relied partly on Project CORE and merger synergies. Rest of World results show that inflation and operating expenses can absorb those benefits.

Summary

Magnera’s fiscal third quarter combined modest reported revenue growth with better gross margins, operating income and adjusted EBITDA, led by price-cost management and Americas performance. However, Rest of World profitability weakened, interest expense kept GAAP earnings negative, and the net loss widened after the prior-year tax benefit reversed. The main areas to monitor are raw-material pass-through, regional margin performance, continued cash generation and execution against the lower end of the company’s adjusted EBITDA guidance range.

This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.